We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · October 21, 2021

Two Sequential Treatments in the First-Line for Metastatic Pancreatic Cancer

Journal of Clinical Oncology


Additional Info

Journal of Clinical Oncology
Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial
J. Clin. Oncol 2021 Oct 10;39(29)3242-3250, L Dahan, N Williet, K Le Malicot, JM Phelip, J Desrame, O Bouché, C Petorin, D Malka, C Rebischung, T Aparicio, C Lecaille, Y Rinaldi, A Turpin, AL Bignon, JB Bachet, JF Seitz, C Lepage, E François

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading